Latest UK kidney data reveals changing picture of kidney care

8 October 2026
More than 74,000 adults in the UK are receiving kidney replacement therapy (KRT), according to the latest data from the UK Renal Registry (UKRR). The UKRR’s 28th Annual Report shows that 74,157 adults were receiving dialysis or living with a functioning kidney transplant at the end of 2024, an...
Read more

Andrew Lewington appointed AKI SIG Medical Co-Chair

8 October 2026
Dr Andrew Lewington has been appointed Medical Co-Chair of the Acute Kidney Injury (AKI) Special Interest Group (SIG), succeeding Professor Jon Murray, who has stepped down from the role. Andrew is a Consultant Renal Physician and Honorary Clinical Associate Professor in Leeds, with more than 20...
Read more

Become the UKKA’s next President

2 October 2026
Help shape the UKKA’s direction, represent medical members and contribute to national conversations about kidney care. We are inviting current UKKA medical members to put themselves forward for election as our next Medical President. "Taking up the role of Medical President for the UKKA has been an...
Read more

DAYLife Highly Commended at Patient Safety Awards

1 October 2026
The DAYLife Shared Haemodialysis Care Mentoring Programme has received a High Commendation at the HSJ Patient Safety Awards 2026 , recognising its work to support the development of shared haemodialysis care across the UK. The programme received the High Commendation in the Patient Safety Education...
Read more

Voting open for Clinical Vice President (Medical)

10 September 2026
Voting is now open for the UKKA Clinical Vice President (Medical) election. This important leadership role represents the medical voice within the Association and contributes to the UKKA’s strategic direction. The Clinical Vice President (Medical) sits on the UKKA Trustee Board and works closely...
Read more

ANN UK officially joins the UKKA

9 September 2026
The Association of Nephrology Nurses UK (ANN UK) has officially become a professional group of the UK Kidney Association, effective from 7 September 2026. The move brings ANN UK and the UKKA together within one professional association, creating a stronger, more connected multiprofessional community...
Read more

The MHRA Suspends Avacopan for New Patients

2 September 2026
Following review, the MHRA has concluded that the available evidence no longer supports a positive benefit-risk balance for Avacopan Vifor (previously known as Tavneos), used in combination with rituximab or cyclophosphamide for adults with severe, active granulomatosis with polyangiitis (GPA) or...
Read more

Transforming community voices into national action

12 August 2026
Over the past 6 months, the kidney community has been campaigning to policymakers for a Kidney Disease Modern Service Framework. October 2025 - open letter calling for a national kidney disease strategy delivered to Prime Minister with over 13,000 signatures February – March 2026 – campaign action...
Read more

Trainee Opportunity: 'Writing to Kidney Patients' Project

4 August 2026
We are seeking a renal trainee to join the UKKA 'Writing to Kidney Patients' project, which aims to develop national, co-produced resources to make kidney clinic communication genuinely patient-centred rather than clinician- or GP-directed. This is an opportunity for a trainee interested in shared...
Read more